WeVote

Bill

Bill

SF 231

A bill for an act relating to prior authorization and utilization review organizations.

2025-2026 Regular Session

SF 231 reforms prior authorization and utilization review processes to improve patient access and reduce administrative burden on Iowa healthcare providers and insurers.

Withdrawn.
0
WeVote Research Nonpartisan
Bill Summary · SF 231

Legislative bill overview

SF 231 relates to prior authorization and utilization review processes in Iowa, likely establishing requirements or reforms for how insurance companies and healthcare networks review and approve medical treatments before they are provided. The bill underwent multiple amendments and procedural changes, ultimately being withdrawn after HF 303 was substituted in its place, suggesting the legislation's provisions were consolidated or superseded by companion legislation.

Why is this important

Prior authorization processes directly affect patient access to timely medical care—delays in approval can postpone necessary treatments. These processes also significantly impact healthcare providers' administrative burdens and costs. Reforms to utilization review standards can influence insurance practices, treatment availability, and overall healthcare efficiency in Iowa.

Potential points of contention

  • Patient access vs. cost control: Streamlining prior authorization improves patient access but may increase insurer costs and potentially insurance premiums
  • Provider burden: Reducing administrative requirements helps healthcare providers but could limit insurers' ability to prevent unnecessary procedures
  • Scope of review: Disagreement over which treatments require prior authorization and what standards utilization review organizations must follow

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.